Drug lag bad: drug lack worse.
出版信息
Br Med J. 1980 Mar 8;280(6215):670.
Abstract
摘要
相似文献
1
Drug lag bad: drug lack worse.药物滞后有害，药物短缺更糟。
Br Med J. 1980 Mar 8;280(6215):670.
2
How bad the drug lag?药物滞后有多严重？
Newsweek. 1978 Oct 9;92(15):119, 121.
3
Drug industry trying to change FDA's slow but sure policy.制药行业正试图改变美国食品药品监督管理局缓慢但可靠的政策。
Natl J (Wash). 1979 Jul 21;11(29):1211-5.
4
Knowledge is power: legislative control of drug industry trade secrets.
Spec Law Dig Health Care (Mon). 1987 May;8(15):7-31.
5
Medical costs and the drug industry.医疗成本与制药行业。
Wall St J Midwest Ed. 1980 Apr 21;60(132):22.
6
The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.1984年《药品价格竞争与专利期限恢复法案》的新影响。
J Contemp Health Law Policy. 1992 Spring;8:361-78.
7
The FDA's restrictions against prescription drug advertising: more hindrance than help.美国食品药品监督管理局对处方药广告的限制：弊大于利。
Healthspan. 1991 Nov;8(10):3-7.
8
Recent developments help the defense of drug companies in 10b-5 cases.近期的发展态势有助于制药公司在10b-5案件中的辩护。
Food Drug Law J. 1996;51(3):345-53.
9
Drug product liability and health care delivery systems.
Stanford Law Rev. 1988 Apr;40(4):989-1026.
10
AIDS and the politics of drug lag.艾滋病与药品滞后的政治问题。
Public Interest. 1989 Summer(96):73-85.
引用本文的文献
1
Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis.日本新药审批格局的演变及其与国际上市日期的差距：回顾性监管分析。
Clin Pharmacol Ther. 2021 May;109(5):1265-1273. doi: 10.1002/cpt.2080. Epub 2020 Nov 15.
本文引用的文献
1
The drug lag revisited: comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976.重新审视药物滞后现象：1972年至1976年美国和英国上市药物模式的治疗领域比较
Clin Pharmacol Ther. 1978 Nov;24(5):499-524. doi: 10.1002/cpt1978245499.
2
Clinically significant adverse effects in a Phase 1 testing program.
Clin Pharmacol Ther. 1978 Aug;24(2):127-32. doi: 10.1002/cpt1978242127.
Zotero 插件